Home Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment
 

Keywords :   


Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

2015-05-31 03:08:15| Biotech - Topix.net

Halozyme Therapeutics, Inc. and Ventana Medical Systems, Inc. , a member of the Roche Group, announced today a global agreement to collaborate on the development of, and for Ventana to ultimately commercialize, a companion diagnostic assay for use with Halozyme's investigational new drug, PEGPH20. The Ventana assay will be used to identify high levels of hyaluronan .

Tags: partner treatment develop cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
22.11Spain fines budget airlines including Ryanair 179m
22.11Eastern North Pacific Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
22.11Rush PANTS
22.11SBS
22.11/
22.11 YOU
22.11
More »